Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
April 2026
Intratubal insemination success, at age 39 – Aslyn’s story
Aslyn, 39, shares her experience choosing FemaSeed intratubal insemination as a less invasive, more affordable alternative to IVF. In partnership with Femasys. Read the full piece at The Ribbon Box →
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.